Monte Rosa Therapeutics, Inc.
GLUE · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$27 | -$12 | $47 | $13 |
| Dep. & Amort. | $3 | $2 | $2 | $2 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $4 | $5 | $5 | $4 |
| Change in WC | $2 | -$29 | -$99 | $110 |
| Other Non-Cash | $118 | -$1 | -$1 | -$1 |
| Operating Cash Flow | $100 | -$35 | -$45 | $129 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$1 | -$2 | -$2 | -$0 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | $0 | -$19 | -$138 | -$68 |
| Inv. Sales/Matur. | $0 | $46 | $39 | $37 |
| Other Inv. Act. | $39 | $0 | $0 | $0 |
| Investing Cash Flow | $38 | $25 | -$100 | -$31 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $0 | $0 | $0 | -$47 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $0 | $0 | $0 | $48 |
| Financing Cash Flow | $0 | $0 | $0 | $1 |
| Forex Effect | $0 | $0 | -$0 | $0 |
| Net Chg. in Cash | $139 | -$9 | -$146 | $99 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $74 | $83 | $224 | $130 |
| End Cash | $213 | $74 | $79 | $229 |
| Free Cash Flow | $100 | -$36 | -$47 | $129 |